Here are the DEF 14A proxy statements from Zura Bio Limited (ZURA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ZURA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZURA filings page.
Zura Bio Limited is asking shareholders to vote at its virtual annual meeting on June 17, 2026, at 12:00 p.m. Eastern Time. Holders of 94,880,710 Class A ordinary shares as of April 20, 2026 can attend online and vote using a control number.
Shareholders will elect eight directors, ratify WithumSmith+Brown, PC as independent auditor for 2026, approve an amended and restated 2023 Equity Incentive Plan, and authorize a potential adjournment to solicit additional proxies. The equity plan amendment keeps the existing share limits but changes the automatic “evergreen” formula so that, starting January 1, 2027, annual share increases can also factor in Class A shares underlying outstanding pre-funded warrants, aligning the pool with the company’s broader economic capitalization.